CT-based dosimetry for transperineal I-125 prostate brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 39, Issue 2 SUPPL., 1997, Pages 347-353

  Willins, John ^a   Wallner, Kent ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Department of Radiation Oncology ^*  (United States)

Author keywords

Brachytherapy; Dosimetry; Prostatic carcinoma

Indexed keywords

IODINE 125;

ARTICLE; BRACHYTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0030866232     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00322-2     Document Type: Article

References (6)

1. Blasko, J. C.; Wallner, K. E.; Grimm, P. D.; Ragde, H. PSA-based disease control following ultrasound-guided I-125 implantation for stage T1/T2 prostatic carcinoma. J. Urol. 154:1096-1099; 1995.
2. Holm, H. H.; Juul, N.; Pederson, J. F.; Hansen, H.; Stroyer, I. Transperineal 125-Iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. J. Urol. 130:283-286, 1983.
3. Roy, J. N.; Wallner, K. E.; Harrington, P. J.; Ling, C. C.; Anderson, L. L. A. CT-based evaluation method for permanent implants: Application to prostate. Int. J. Radiat. Oncol. Biol. Phys. 26:163-169; 1993.
4. Wallner, K. E.; Roy, J.; Zelefsky, M.; Fuks, Z.; Harrison, L. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 32:465-471; 1995.
5. Wallner, K. E.; Roy, J.; Harrison, L. Tumor control and morbidity following transperineal I-125 implantation for Stage T1/T2 prostatic carcinoma. J. Clin. Oncol. 14:449-453; 1996.
6. Yu, Y. U.; Waterman, F. M.; Suntharalingham, N.; Schulsinger, A. Limitations of the minimum peripheral dose as a parameter for dose specification in permanent I-125 prostate implants. Int. J. Radiat. Oncol. Biol. Phys. 34:717-725; 1996.